Basit öğe kaydını göster

dc.contributor.authorKeeley, Vaughan
dc.contributor.authorFranks, Peter
dc.contributor.authorQuéré, Isabelle
dc.contributor.authorMercier, Gregoire
dc.contributor.authorMichelini, Sandro
dc.contributor.authorCestari, Marina
dc.contributor.authorBorman, Pinar
dc.contributor.authorHughes, Andrew
dc.contributor.authorClark, Kath
dc.contributor.authorLisle, Jill
dc.contributor.authorBenson, Margaret
dc.contributor.authorNøerregaard, Susan
dc.contributor.authorKarlsmark, Tonny
dc.contributor.authorMurray, Susie
dc.contributor.authorMoffatt, Christine
dc.date.accessioned2021-06-03T04:57:57Z
dc.date.available2021-06-03T04:57:57Z
dc.date.issued2019
dc.identifier.issn1539-6851
dc.identifier.urihttp://dx.doi.org/10.1089/lrb.2019.0021
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639110/
dc.identifier.urihttp://hdl.handle.net/11655/23894
dc.description.abstractBackground: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences., Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema., Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with “younger” services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.
dc.language.isoen
dc.relation.isversionof10.1089/lrb.2019.0021
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleLimprint In Specialist Lymphedema Services In United Kingdom, France, Italy, And Turkey
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalLymphatic Research And Biology
dc.contributor.departmentFiziksel Tıp ve Rehabilitasyon
dc.identifier.volume17
dc.identifier.issue2
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Attribution 4.0 United States
Aksi belirtilmediği sürece bu öğenin lisansı: Attribution 4.0 United States